Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ADA 2014: Diabetes Players Move Closer To An Artificial Pancreas

Executive Summary

The quest to bring an artificial pancreas to market has taken some giant steps forward recently, as major players continue to produce impressive data from clinical studies that measure the use of various insulin pumps, continuous glucose monitors (CGMs), and algorithms. Improvements in CGM sensor technology have helped move AP research, and competition is proving to be a driving force on the road to producing a commercial product that could be within two or three years from reaching the market.

You may also be interested in...



Diabetes Market Sees Advances In CGMs, Artificial Pancreas Systems, And Connectivity

The focus of the diabetes market is firmly on the development of an artificial pancreas, now within two or three years from becoming commercialized, and progress is going so well that several companies are in line to release a product. Meanwhile, digital health is increasingly playing a major role in diabetes care, and device manufacturers are investing in connectivity solutions to satisfy patient and consumer needs.

Abbott Earns CE Mark For FreeStyle Libre Bloodless Glucose Monitor

FreeStyle Libre reads glucose levels through a interstitial fluid sensor on the back of the patient’s arm, but unlike current continuous glucose monitors does not require finger-stick calibrations.

Apps Ahead For Diabetes: Q&A With DexCom’s Terry Gregg

Continuous glucose monitor developer DexCom is staking its future on an app-based platform for sensor-insulin pump systems. CEO Terrance Gregg offers an update on the company’s efforts, his thoughts on the space and the growing interest in glucose monitoring by big tech firms like Apple and Google.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT035802

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel